Summary
Major depressive disorder (MDD), also known as clinical depression or major depression, is widely recognized as one of the most common mental disorders in the world. MDD is a type of mood disorder characterized by persistent feelings of sadness, anger, loss, or frustration that can last from days to months and alternates with episodes of wellness. MDD is a highly debilitating condition that is associated with substantial morbidity and an enormous social and economic burden.
The condition affects the thoughts, feelings, behavior, and physical health of an individual, leading to a range of psychological, physical, and social problems.
GlobalData epidemiologists forecast that the total prevalent cases of MDD in the 8MM will grow by 4.0% over the next decade, from 31,798,832 total prevalent cases in 2013 to 33,083,108 total prevalent cases in 2023. GlobalData epidemiologists attribute the growth in the total prevalent cases of MDD in the 8MM to changing population demographics in the respective markets, rather than to an actual increase in the prevalence of MDD in these markets.
Click for report details: http://www.radiantinsights.com/research/epicast-report-major-depressive-disorder-epidemiology-forecast-to-2023
GlobalData's epidemiological forecast for the total prevalent cases of MDD in the 8MM is supported by epidemiologic data from country-specific studies that are nationally representative of the entire population in these markets.
GlobalData's epidemiological analysis included the most recently published nationally-representative studies in the 8MM that provided the total prevalence of MDD using the DSM-IV diagnostic criteria and the CIDI version 3.0, which facilitates for a meaningful comparison of the forecast total prevalent cases of MDD in the 8MM. Additionally, the use of the total prevalence to forecast the total prevalent cases of MDD in the 8MM further strengthens GlobalData's epidemiological analysis, because the total prevalence reflects the true burden of a highly undiagnosed disease like MDD.
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
For More Information Visit – Radiant Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Major depressive disorder (MDD), also known as clinical depression or major depression, is widely recognized as one of the most common mental disorders in the world. MDD is a type of mood disorder characterized by persistent feelings of sadness, anger, loss, or frustration that can last from days to months and alternates with episodes of wellness. MDD is a highly debilitating condition that is associated with substantial morbidity and an enormous social and economic burden.
The condition affects the thoughts, feelings, behavior, and physical health of an individual, leading to a range of psychological, physical, and social problems.
GlobalData epidemiologists forecast that the total prevalent cases of MDD in the 8MM will grow by 4.0% over the next decade, from 31,798,832 total prevalent cases in 2013 to 33,083,108 total prevalent cases in 2023. GlobalData epidemiologists attribute the growth in the total prevalent cases of MDD in the 8MM to changing population demographics in the respective markets, rather than to an actual increase in the prevalence of MDD in these markets.
Click for report details: http://www.radiantinsights.com/research/epicast-report-major-depressive-disorder-epidemiology-forecast-to-2023
GlobalData's epidemiological forecast for the total prevalent cases of MDD in the 8MM is supported by epidemiologic data from country-specific studies that are nationally representative of the entire population in these markets.
GlobalData's epidemiological analysis included the most recently published nationally-representative studies in the 8MM that provided the total prevalence of MDD using the DSM-IV diagnostic criteria and the CIDI version 3.0, which facilitates for a meaningful comparison of the forecast total prevalent cases of MDD in the 8MM. Additionally, the use of the total prevalence to forecast the total prevalent cases of MDD in the 8MM further strengthens GlobalData's epidemiological analysis, because the total prevalence reflects the true burden of a highly undiagnosed disease like MDD.
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
For More Information Visit – Radiant Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
No comments:
Post a Comment